27.27
2.19%
-0.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Royalty Pharma plc Borsa (RPRX) Ultime notizie
Panagora Asset Management Inc. Buys 215,142 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
Shareholders in Royalty Pharma (NASDAQ:RPRX) are in the red if they invested a year ago - Yahoo Sport Australia
Yahoo Sport Australia
Charles Schwab Investment Management Inc. Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Amalgamated Bank Sells 3688 Shares of Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
National Bank of Canada FI Has $986,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by National Bank of Canada FI - Defense World
Defense World
Teacher Retirement System of Texas Reduces Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Victory Capital Management Inc. Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Victory Capital Management Inc. Has $7.46 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
M&T Bank Corp Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Torray Investment Partners LLC Increases Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
(RPRX) Investment Report - Stock Traders Daily
Stock Traders Daily
Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Van ECK Associates Corp Buys 2944 Shares of Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Royalty Pharma plc (NASDAQ:RPRX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Simply Wall St
Simply Wall St
Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results - Yahoo Finance UK
Yahoo Finance UK
Metis Global Partners LLC Invests $375000 in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by StockNews.com - Defense World
Defense World
Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend - Yahoo Finance UK
Yahoo Finance UK
Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by StockNews.com - MarketBeat
MarketBeat
Royalty Pharma Stock: Solid Start Of The Year, Buy Confirmed (NASDAQ:RPRX) - Seeking Alpha
Seeking Alpha
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight - Yahoo Finance
Yahoo Finance
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com Australia
Investing.com Australia
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com
Investing.com
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com India
Investing.com India
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab - citybiz
citybiz
Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Zacks Investment Research
Zacks Investment Research
Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Yahoo Finance
Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Yahoo Finance
Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates - Zacks Investment Research
Zacks Investment Research
Royalty Pharma Reports First Quarter 2024 Results - 09.05.2024 - wallstreet:online
wallstreet:online
Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Sanofi's (SNY) Frexalimab - StreetInsider.com
StreetInsider.com
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire Inc.
The Best Healthcare Stocks to Buy - Morningstar
Morningstar
Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Surpass Estimates
Zacks Investment Research
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Swiss National Bank - MarketBeat
MarketBeat
Why Earnings Season Could Be Great for Royalty Pharma (RPRX) - Zacks Investment Research
Zacks Investment Research
RPRX Breaks Above 3% Yield Territory - Nasdaq
Nasdaq
Why Earnings Season Could Be Great for Royalty Pharma (RPRX)
Zacks Investment Research
RPRX Breaks Above 3% Yield Territory - Nasdaq
Nasdaq
Russell Investments Group Ltd. Purchases 54,907 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
Royalty Pharma (RPRX) Scheduled to Post Quarterly Earnings on Thursday - Defense World
Defense World
Royalty Pharma plc (NASDAQ:RPRX) Receives $46.75 Consensus Target Price from Analysts - MarketBeat
MarketBeat
Royalty Pharma (RPRX) Scheduled to Post Quarterly Earnings on Thursday - Defense World
Defense World
Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics
Zacks Investment Research
Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics - Nasdaq
Nasdaq
Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics - Zacks Investment Research
Zacks Investment Research
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by First Trust Direct Indexing L.P. - Defense World
Defense World
Capitalizzazione:
|
Volume (24 ore):